Literature DB >> 12454167

Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.

Francesco Broccolo1, Giuseppe Locatelli, Loredana Sarmati, Sara Piergiovanni, Fabrizio Veglia, Massimo Andreoni, Stefano Buttò, Barbara Ensoli, Paolo Lusso, Mauro S Malnati.   

Abstract

Accurate laboratory tests for the diagnosis of active human herpesvirus 8 (HHV-8) infection are becoming essential to study the pathogenesis of HHV-8-associated tumors and for the clinical management of HHV-8-infected individuals. We have developed a highly sensitive, calibrated quantitative real-time PCR assay for the measurement of cell-free HHV-8 DNA in body fluids, based on the addition of a synthetic DNA calibrator prior to DNA extraction. The calibrator controls each sample for the presence of PCR inhibitors, determines a cutoff value of sensitivity for negative samples, and normalizes positive samples for the efficiency of DNA recovery. The assay shows a wide dynamic range of detection (between 1 and 10(6) viral genome equivalents/reaction) and a high degree of accuracy even in the presence of high amounts (up to 1 micro g) of human genomic DNA. Moreover, the assay has a very high sensitivity (lower detection limit, 10 genome equivalents/ml) and a high degree of reproducibility and repeatability with a coefficient of variation (CV) of <15 and 23%, respectively. Furthermore, the use of the calibrator improves the accuracy of quantitation and decreases the intersample variability (CV, 9 and 6%, respectively). The sensitivity and specificity of the assay were tested with a series of clinical specimens obtained from patients affected by various HHV-8-related diseases, as well as from a wide number of controls. In conclusion, our calibrated real-time PCR assay provides a reliable high-throughput method for quantitation of HHV-8 DNA in clinical and laboratory specimens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454167      PMCID: PMC154587          DOI: 10.1128/JCM.40.12.4652-4658.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS.

Authors:  R Mazzi; S G Parisi; L Sarmati; I Uccella; E Nicastri; G Carolo; F Gatti; E Concia; M Andreoni
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

2.  Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.

Authors:  L P Jacobson; F J Jenkins; G Springer; A Muñoz; K V Shah; J Phair; Z Zhang; H Armenian
Journal:  J Infect Dis       Date:  2000-05-26       Impact factor: 5.226

3.  Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.

Authors:  T J Spira; L Lam; S C Dollard; Y X Meng; C P Pau; J B Black; D Burns; B Cooper; M Hamid; J Huong; K Kite-Powell; P E Pellett
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype.

Authors:  R J Biggar; D Whitby; V Marshall; A C Linhares; F Black
Journal:  J Infect Dis       Date:  2000-05-08       Impact factor: 5.226

5.  Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.

Authors:  F Lallemand; N Desire; W Rozenbaum; J C Nicolas; V Marechal
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.

Authors:  R Tedeschi; M Enbom; E Bidoli; A Linde; P De Paoli; J Dillner
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens.

Authors:  F R Stamey; M M Patel; B P Holloway; P E Pellett
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

8.  Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.

Authors:  O Schatz; P Monini; R Bugarini; F Neipel; T F Schulz; M Andreoni; P Erb; M Eggers; J Haas; S Buttò; M Lukwiya; J R Bogner; S Yaguboglu; J Sheldon; L Sarmati; F D Goebel; R Hintermaier; G Enders; N Regamey; M Wernli; M Stürzl; G Rezza; B Ensoli
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

9.  Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy.

Authors:  Mauro Malnati; Francesco Broccolo; Silvia Nozza; Loredana Sarmati; Silvia Ghezzi; Giuseppe Locatelli; Fanny Delfanti; Brunella Capiluppi; Anna Careddu; Massimo Andreoni; Paolo Monini; Guido Poli; Adriano Lazzarin; Paolo Lusso; Giuseppe Tambussi
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

10.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

View more
  14 in total

1.  Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.

Authors:  Abeltje M Polstra; Remco Van Den Burg; Jaap Goudsmit; Marion Cornelissen
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS.

Authors:  Anna Casabianca; Chiara Orlandi; Alessandra Fraternale; Mauro Magnani
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.

Authors:  Andrea Lisco; Jean-Charles Grivel; Angélique Biancotto; Christophe Vanpouille; Francesco Origgi; Mauro S Malnati; Dominique Schols; Paolo Lusso; Leonid B Margolis
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

4.  Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Authors:  Francois Rouet; Didier K Ekouevi; Marie-Laure Chaix; Marianne Burgard; Andre Inwoley; Thomas D'Aquin Tony; Christine Danel; Xavier Anglaret; Valeriane Leroy; Philippe Msellati; Francois Dabis; Christine Rouzioux
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome.

Authors:  Ivan M Petyaev; Nayilia A Zigangirova; Alexey M Petyaev; Ulia P Pashko; Lubov V Didenko; Elena U Morgunova; Yuriy K Bashmakov
Journal:  Int J Med Sci       Date:  2010-06-10       Impact factor: 3.738

6.  Chronic human herpes virus 8 infection successfully treated with valganciclovir.

Authors:  James J Yun; Veronica Preda; Brad Frankum
Journal:  World Allergy Organ J       Date:  2009-07       Impact factor: 4.084

7.  Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.

Authors:  Christophe Vanpouille; Angélique Biancotto; Andrea Lisco; Beda Brichacek
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

8.  Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection.

Authors:  Elisa Martró; Michael J Cannon; Sheila C Dollard; Thomas J Spira; A Scott Laney; Chin-Yih Ou; Philip E Pellett
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.

Authors:  Francesco Broccolo; Paolo Lusso; Mauro Malnati
Journal:  J Clin Microbiol       Date:  2013-06       Impact factor: 5.948

10.  Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types.

Authors:  Roberto Flores-Munguia; Erin Siegel; Walter T Klimecki; Anna R Giuliano
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.